SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-09-000129
Filing Date
2009-02-02
Accepted
2009-02-02 16:07:50
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 flamel_sc13ga.htm SC 13G/A 303854
  Complete submission text file 0000898432-09-000129.txt   305898
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address
Business Address PARC CLUB DU MOULIN A VENT 33 AVE DU DOCTEUR GEORGES LEVY VENISSIEUX CED I0 69693 2126641666
FLAMEL TECHNOLOGIES SA (Subject) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50223 | Film No.: 09561586
SIC: 2834 Pharmaceutical Preparations